DIXON WENDY L 4
4 · Black Diamond Therapeutics, Inc. · Filed May 17, 2023
Insider Transaction Report
Form 4
DIXON WENDY L
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-16+16,500→ 16,500 totalExercise: $1.82Exp: 2033-05-15→ Common Stock (16,500 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 16, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.